Namwiwat Medical Corp PCL

Namwiwat Medical Corp PCL maintains a strong liquidity position with a current ratio of 8.91, indicating a high ability to meet short-term obligations. However, the company reported negative operating cash flow of -48,123,590 THB and free cash flow of -12,124,070 THB, suggesting cash outflows from operations. The capital expenditure of -33,648,790 THB reflects ongoing investment in long-term assets. Profitability metrics show a return on equity (ROE) of 0.67% and a return on assets (ROA) of 0.58%, both below the typical thresholds for high-performing healthcare firms. The company's operating income of 21,332,120 THB and net income of 13,269,070 THB indicate modest profitability relative to its asset base. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic or regulatory shifts. Outlook for the current fiscal year shows a projected revenue growth of 0.00%, with no significant changes expected in the next fiscal year. The company's historical revenue of 200,446,110 THB reflects a stable but non-expanding business model. Risk factors include a medium liquidity risk due to negative net cash after subtracting total debt. The dilution risk is assessed as low, with no near-term pressure from share issuance or convertible instruments. The company's debt-to-equity ratio of 0.09 suggests a conservative capital structure. Recent filings and transcripts do not disclose any material events or strategic shifts. The company's financial statements remain consistent with prior periods, with no significant changes in operations or capital structure.